BR-1015
- Generic Name
- BR-1015
A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT05097794
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Gyeonggi-do, Seongnam-si, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath